NATIONAL PATTERNS OF ELIGIBILITY AND USE OF NOVEL LIPID LOWERING THERAPIES IN THE UNITED STATES

被引：0
|
作者：
Shen, Miles [1 ]
Nargesi, Arash Aghajani [1 ]
Nasir, Khurram [1 ]
Khera, Rohan [1 ]
机构：
[1] Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2022年 / 79卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1563 / 1563
页数：1
相关论文
共 50 条
  • [1] Contemporary National Patterns of Eligibility and Use of Novel Lipid-Lowering Therapies in the United States
    Shen, Miles
    Nargesi, Arash Aghajani
    Nasir, Khurram
    Bhatt, Deepak L.
    Khera, Rohan
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2022, 11 (18):
  • [2] Use of antiepileptic drugs and lipid-lowering agents in the United States
    Mintzer, Scott
    Maio, Vittorio
    Foley, Kathleen
    EPILEPSY & BEHAVIOR, 2014, 34 : 105 - 108
  • [3] Understanding the Prescribing Patterns of Lipid-Lowering Agents in the United States and Canada
    Reynolds, Matthew W.
    Moride, Yola
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S1 - S1
  • [4] Patterns of Lipid Lowering Therapy Use Among Older Adults in a Managed Care Advantage Plan in the United States
    Vadhariya, Aisha
    Sharma, Manvi
    Abughosh, Susan M.
    Birtcher, Kim K.
    Chen, Hua
    Mohan, Anjana
    Johnson, Michael L.
    JOURNAL OF PHARMACY PRACTICE, 2024, 37 (01) : 123 - 131
  • [5] National patterns of calcium use in osteoporosis in the United States
    Stafford, RS
    Drieling, RL
    Johns, R
    Ma, J
    JOURNAL OF REPRODUCTIVE MEDICINE, 2005, 50 (11) : 885 - 890
  • [6] National patterns and correlates of mentholated cigarette use in the United States
    Lawrence, Deirdre
    Rose, Allison
    Fagan, Pebbles
    Moolchan, Eric T.
    Gibson, James Todd
    Backinger, Cathy L.
    ADDICTION, 2010, 105 : 13 - 31
  • [7] Prescribing Patterns of Onychomycosis Therapies in the United States
    Yang, Eric J.
    Lipner, Shari R.
    CUTIS, 2020, 106 (06): : 326 - 327
  • [8] Patient Characteristics and Lipid Lowering Treatment of Early Adopters of PCSK9i Therapies in the United States
    Mues, Katie
    Bratton, Emily
    Wirtz, Heidi S.
    Maya, Juan F.
    Muntner, Paul M.
    Wang, Tracy Y.
    CIRCULATION, 2017, 136
  • [9] Novel lipid-lowering therapies and cardiovascular risk management
    Rizzo, M.
    CARDIOLOGY, 2013, 126 : 26 - 26
  • [10] Novel Lipid-Lowering Therapies to Reduce Cardiovascular Risk
    Wilkins, John T.
    Lloyd-Jones, Donald M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (03): : 266 - 267
12345